SWAV - Oppenheimer sees 26% downside in Intuitive Surgical in premarket action April, 01 2020 07:51 AM ShockWave Medical Inc. Apellis Pharmaceuticals (NASDAQ:APLS) initiated with Strong Buy rating and $86 (221% upside) price target at Raymond James.More news on: Apellis Pharmaceuticals, Inc., BioXcel Therapeutics, Inc., Eidos Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...